A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
about
Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian childrenHybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequenceClinical significance of HIV-1 coreceptor usage.Bioinformatic analysis of HIV-1 entry and pathogenesis.Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usageCellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in EuropeViremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and functionReliable genotypic tropism tests for the major HIV-1 subtypesPhylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispeciesHIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region.Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmissionHost and viral genetic correlates of clinical definitions of HIV-1 disease progression.Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage.Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.Tropism testing in the clinical management of HIV-1 infection.Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy.Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C virusesExtreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.Multiple independent lineages of HIV-1 persist in breast milk and plasma.Distribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naïve vs. experienced patients.Different regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission.Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops.Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rateNeutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.Diversity of HIV type 1 envelope (V3-V5) sequence in HIV type 1-infected Indian children.Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive ImmunizationSexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates.Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.HIV coreceptor tropism determination and mutational pattern identification.CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm
P2860
Q21261525-EEABDE8B-214D-409D-BAB3-017289AE4C5DQ21559666-EAAE947D-8ED7-4838-98DA-3847993446B2Q27691426-00E6B201-DF0A-4E96-B2CB-78206BA4E9A0Q27693321-01A177E9-4ACD-4BBD-BDDD-152399BA9A00Q28469177-B6F6426D-47FA-49EB-AF72-104406041921Q28474278-8BC5BE89-A711-4F69-9FC8-CDB7E519DD10Q28732293-5A5E3B83-284E-410A-A523-467BD5D5A05AQ30372085-13EB29A8-F0BD-4809-9F99-993AF43EA5E8Q30834495-28D102CB-484B-4508-9187-00F0E0502C90Q33388932-E970844F-7C92-482B-8C9D-61511AAA0A1BQ33565651-9A4DD5DB-45C1-4B6F-B4A2-4D9772378500Q33605758-504CAEFE-2E11-4623-8441-B27E1654B811Q33636669-D1B8707F-A460-45AF-A59A-C66B3464A635Q33711003-4725EE66-A160-406C-9BC7-E001EC380EBBQ33851789-09D53376-A77B-4E16-A3F1-D2B46F57989DQ33869686-8816BEEC-AE2A-4579-A0CC-014B5BAB8CBCQ33963459-CD6C1912-CD58-4ACD-A1F0-AD09A3277BC8Q34053466-2E586C22-064D-452F-96D0-F98578273145Q34055508-7C670040-F3F5-4789-B746-130FE0FD59EBQ34269253-0761FDB6-DE51-4240-BF75-DB4A17025B42Q34400487-B9DB6D0D-FD7C-470D-9EC8-0B302AF151B6Q34425169-12D5F647-0B6B-4207-84A3-6F1815EC49C4Q34544952-D29FF50D-D231-406F-812B-BF9270671066Q34727711-58416007-63A9-4C55-8DB2-140D43D9E5CBQ35077772-0DD4F94B-E52E-4DEF-98BF-BD437DE59DBEQ35133895-C8454D6F-92B9-4F73-B79B-53BD6134E605Q35330357-B77DBCE0-890B-4747-953F-F14E88934312Q35666270-FF2BCE16-1B3A-4B3C-A28A-81ED304008E6Q35842723-E769139F-C0F3-4600-91F2-EA4DBFF63E64Q35857268-33961279-8349-47FA-AEC0-C5266F67C469Q35862329-BF1078E4-B290-436C-AE8C-C2A3FD0017FAQ35904487-21DE96B7-C5D3-4857-AACB-E161A61EFF54Q35947561-7F90B10D-7AE4-4F47-B870-5BDDE3C3089EQ36081789-D5568409-66EE-4B64-B75D-EAE4022CC22AQ36359817-C5A7236F-7547-4DCE-9050-2394B022C714Q36382002-C29281AD-ED56-4AF2-A245-7ECDB6B6FECCQ36497842-24FB4D8F-1E50-4207-BB28-6374AA75AB4DQ36539298-F04ECA35-A10F-4477-98F4-49F3CE9AFB3EQ36588528-9E693D52-EA65-48D4-B62D-102169739B1BQ36690585-06AC1E5F-8E03-452C-8A78-26B5474D8DE7
P2860
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@ast
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@en
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@nl
type
label
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@ast
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@en
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@nl
prefLabel
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@ast
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@en
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@nl
P2093
P2860
P1433
P1476
A reliable phenotype predictor ...... ased on envelope V3 sequences.
@en
P2093
Angélique B van 't Wout
James I Mullins
Mark A Jensen
Mia Coetzer
P2860
P304
P356
10.1128/JVI.80.10.4698-4704.2006
P407
P50
P577
2006-05-01T00:00:00Z